FDA Alert
FDA Alert
09/30/2024
Miranda Manier, BA
Two randomized, double-blind studies demonstrated that a new antipsychotic treatment for adult patients with schizophrenia may lead to a meaningful reduction in symptoms.
09/30/2024
Research summary
Research summary
08/15/2024
Jessica Ganga
Researchers sought to evaluate the risk of patients newly diagnosed with alopecia areata developing psychiatric or autoimmune disease after diagnosis.
08/15/2024
Research summary
Research summary
05/23/2024

Jessica Ganga

Jessica Ganga
A team of researchers examined the possibility of harmful risks associated with the discontinuation of long-term benzodiazepine use in patients.
05/23/2024
research summary
research summary
03/11/2024

Leigh Precopio

Leigh Precopio
Researchers examined how the availability of mental health services and patient specific characteristics impacted levels of anxiety and depression in residents of long-term care settings following COVID-19...
03/11/2024
research summary
research summary
03/01/2024

Jessica Ganga

Jessica Ganga
Researchers examined the characteristics and trends related to the increased mortality rates associated with overdose in pregnant and postpartum women.
03/01/2024
FDA Alert
FDA Alert
10/04/2023
Jessica Ganga
Following two randomized studies, the FDA has approved zuranolone for the treatment of postpartum depression in adults—the first if its kind.
10/04/2023
Research summary
Research summary
07/28/2023
Jessica Ganga
The USPSTF has updated its recommendations on screening adults for major depressive disorder (MDD) and suicide risk.
07/28/2023
Stress Reduction
Stress Reduction
12/08/2022
The use of mindfulness-based treatments for individuals with anxiety disorders is as effective as a common antidepressant medication, according to the authors of a recent study.
12/08/2022
Depression
Depression
10/14/2022
Psych Congress cochair Charles Raison, MD, discusses the risks that patients face when stopping an antidepressant and possible problems with restarting it.
10/14/2022
management
management
09/23/2022
A joint clinical practice guideline on the management of major depressive disorder was released earlier this year, which included 36 recommendations on screening, monitoring, and treating this condition. ...
09/23/2022